These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 7533939)
1. [Cardiac side effects and ECG changes with lamotrigine?--A clinical study]. Steinhoff BJ; Stodieck SR; Tiecks FP; Wedel R; Polatschek B Schweiz Arch Neurol Psychiatr (1985); 1994; 145(3):8-12. PubMed ID: 7533939 [TBL] [Abstract][Full Text] [Related]
2. [The use of lamotrigine in female patients]. Schmitz B; Bergmann L Nervenarzt; 2007 Aug; 78(8):912-22. PubMed ID: 16523355 [TBL] [Abstract][Full Text] [Related]
3. [Lamotrigine in refractory partial and general epilepsies]. Mauri-Llerda JA; Tejero C; Espada F; Iñiguez C; Morales F Rev Neurol; 2001 Jan 1-15; 32(1):42-5. PubMed ID: 11293097 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of lamotrigine add-on therapy in severe partial epilepsy in adults with drop seizures and secondary bilateral synchrony on EEG. Bisulli F; Baruzzi A; Rosati A; Riva R; Avoni P; Cerullo A; Tinuper P Epileptic Disord; 2001 Sep; 3(3):151-6. PubMed ID: 11679308 [TBL] [Abstract][Full Text] [Related]
5. Cardiac function and antiepileptic drug treatment in the elderly: a comparison between lamotrigine and sustained-release carbamazepine. Saetre E; Abdelnoor M; Amlie JP; Tossebro M; Perucca E; Taubøll E; Anfinsen OG; Isojärvi J; Gjerstad L Epilepsia; 2009 Aug; 50(8):1841-9. PubMed ID: 19400874 [TBL] [Abstract][Full Text] [Related]
6. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults. Steinhoff BJ; Ueberall MA; Siemes H; Kurlemann G; Schmitz B; Bergmann L; Seizure; 2005 Dec; 14(8):597-605. PubMed ID: 16278088 [TBL] [Abstract][Full Text] [Related]
7. Assessment of tolerability in elderly patients: changing to lamotrigine therapy. Evans BK; Kustra RP; Hammer AE Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy. Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941 [TBL] [Abstract][Full Text] [Related]
10. [Lamotrigine in the adult-onset epilepsy: efficacy and long-term safety]. Alegre M; Iriarte J; Schlumberger E; Urrestarazu E; Lázaro D; Viteri C Neurologia; 2002 Mar; 17(3):136-42. PubMed ID: 11927102 [TBL] [Abstract][Full Text] [Related]
11. Signal-averaged and standard electrocardiography in patients with newly diagnosed epilepsy. Svalheim S; Aurlien D; Amlie JP; Gjerstad L; Taubøll E Epilepsy Behav; 2012 Dec; 25(4):543-5. PubMed ID: 23153719 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study. Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148 [TBL] [Abstract][Full Text] [Related]
13. Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study. Zeng QY; Fan TT; Zhu P; He RQ; Bao YX; Zheng RY; Xu HQ PLoS One; 2015; 10(7):e0131566. PubMed ID: 26147937 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of antiepileptic drugs on sexual function and reproductive hormones in men with epilepsy: interim analysis of a comparison between lamotrigine and enzyme-inducing antiepileptic drugs. Herzog AG; Drislane FW; Schomer DL; Pennell PB; Bromfield EB; Kelly KM; Farina EL; Frye CA Epilepsia; 2004 Jul; 45(7):764-8. PubMed ID: 15230699 [TBL] [Abstract][Full Text] [Related]
15. Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine. Sethi A; Chandra D; Puri V; Mallika V Neurol India; 2002 Sep; 50(3):359-63. PubMed ID: 12391470 [TBL] [Abstract][Full Text] [Related]
16. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878 [TBL] [Abstract][Full Text] [Related]
17. Agranulocytosis associated with lamotrigine in a patient with low-grade glioma. Fadul CE; Meyer LP; Jobst BC; Cornell CJ; Lewis LD Epilepsia; 2002 Feb; 43(2):199-200. PubMed ID: 11903469 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of lamotrigine in patients suffering from resistant partial seizures. Benetello P; Furlanut M; Baraldo M; Tonon A; Furlanut M Eur Neurol; 2002; 48(4):200-3. PubMed ID: 12422067 [TBL] [Abstract][Full Text] [Related]
19. Prospective study on concentration-efficacy and concentration-toxicity: correlations with lamotrigine serum levels. Fröscher W; Keller F; Vogt H; Krämer G Epileptic Disord; 2002 Mar; 4(1):49-56. PubMed ID: 11967180 [TBL] [Abstract][Full Text] [Related]
20. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy. Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]